Biodesix, Inc.
BDSX
$24.00
$0.210.88%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.11% | -11.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.11% | -11.13% | |||
| Cost of Revenue | 4.67% | -5.62% | |||
| Gross Profit | 5.21% | -12.25% | |||
| SG&A Expenses | 0.09% | 5.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.27% | 4.65% | |||
| Operating Income | 18.50% | -235.50% | |||
| Income Before Tax | 6.67% | -95.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.67% | -95.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.67% | -95.80% | |||
| EBIT | 18.50% | -235.50% | |||
| EBITDA | 23.29% | -798.10% | |||
| EPS Basic | 12.48% | -63.55% | |||
| Normalized Basic EPS | 16.83% | -71.85% | |||
| EPS Diluted | 12.48% | -63.55% | |||
| Normalized Diluted EPS | 16.83% | -71.85% | |||
| Average Basic Shares Outstanding | 6.63% | 19.73% | |||
| Average Diluted Shares Outstanding | 6.63% | 19.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||